HOME >> BIOLOGY >> NEWS
Sequencing Milestone Reached By DOE Joint Genome Institute

A significant milestone in deciphering the human genetic code -- the completion of a major gene sequencing goal by the Department of Energy's Joint Genome Institute (JGI) -- will be announced on Friday, October 23, at Lawrence Berkeley National Laboratory's Genome Sciences Building. This achievement places the JGI effort as the third worldwide in terms of its total contribution of publicly available DNA sequence.

The JGI is a consortium of scientists, engineers and staff from the Lawrence Berkeley, Lawrence Livermore, and Los Alamos National Laboratories. They are key players in an international effort to determine the 3 billion base pairs ("letters") that comprise the human genome within the next five years -- an achievement that promises untold opportunities to improve health and advances in disease treatment and cure.

In addition to celebrating the technological successes of the JGI, DOE and laboratory officials will be available to discuss the new accelerated five-year plan developed by the DOE and National Institutes of Health to complete the mapping program. The plan will be officially described in Science magazine's October 23 issue (copies of the report will be available at the event).

The media will also be provided with a 20-minute laboratory tour to explain JGI's sequencing program. Operating robotic systems will be activated to provide interesting visuals for television.

Participating will be Martha Krebs, the DOE's Director of the Office of Energy Research; Ari Patrinos, DOE's Director of the Office of Biological and Environmental Sciences; and Elbert Branscomb, Director of the Joint Genome Institute. All will be available to answer questions following the tour.

WHAT: SEQUENCING MILESTONE ANNOUNCEMENT

WHERE: LAWRENCE BERKELEY NATIONAL LABORATORY
Building 84 (Genome Sciences Building) Lobby

WHEN: Friday, October 23, 1998, 10-11 a.m.

PARKING: Space must be reserved by calling (
'"/>

Contact: Ron Kolb
RRKolb@lbl.gov
510-486-7586
DOE/Lawrence Berkeley National Laboratory
19-Oct-1998


Page: 1 2

Related biology news :

1. Sequencing project results in six-fold reduction of effective size of maize genome
2. NSF awards $4.3 million to Rutgers for Maize Genome Sequencing Project
3. Sequencing the human genome: unraveling the mysteries of health and disease
4. Artificial Gels Could Speed DNA Sequencing
5. Whitehead Receives $7 million NIH Grant To Build High-Speed Sequencing Machines
6. Hopkins Scientists Sequencing Of AIDS Virus From India Waves A Red Flag For Vaccine Developers
7. DOE Joint Human Genome Effort Exceeds Sequencing Goal
8. Harvard Medical School Researchers Present Atomic Structure Of DNA-Replicating Enzyme Widely Used In DNA Sequencing
9. Milestone In Mitochondrial Structure Revealed
10. Structure Of Tumor Necrosis Factor-Alpha-Converting Enzyme Solved - Milestone Toward Rational Drug Design For Rheumatoid Arthritis And Endotoxic Shock
11. E. Coli Genome Reported: Milestone Of Modern Biology Emerges From Wisconsin Lab

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sequencing Milestone Reached DOE Joint Genome Institute

(Date:8/12/2015)... YORK , Aug. 12, 2015  New ... hackers can attack Android phones to steal users, ... the increasing availability of fingerprint scanners on mobile ... utmost concern. To secure biometrics on mobile devices, ... to augment these convenient authentication systems with strong ...
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cbgl72/middle_east_and ) has announced the ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Middle East & Africa Biomedical Sensors ... a CAGR of 3.26% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/31/2015)... Aug. 31, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... the 30-day review period following the filing of ... indications with the U.S. Food and Drug Administration ... active. Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:8/31/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 31, 2015 ... on the discovery and development of novel cancer immunotherapies, ... , M.D., Ph.D., as Chief Executive Officer and ... Drs. Wong and Ho join an experienced management team ... company: Jordan Fridman , Ph.D., Chief Scientific Officer; ...
(Date:8/31/2015)... ... 31, 2015 , ... Regulatory agencies have acknowledged impurities especially ... process. Thus, innovator companies must understand what will be needed in the drug ... been hosting multiple educational panels and seminars for experts to share advice concerning ...
Breaking Biology Technology:Middle East & Africa Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts to 2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
Cached News: